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FEV1, FEV1/FVC, and PEFR are well established in provid-
ing an objective measure of improvements in airflow after
a therapeutic intervention. However, assessments of dyspnea,
functional status, and overall heath status are required to
characterize response to treatment. The most widely used dis-
ease-specific health status questionnaire for patients with
obstructive lung disease is the SGRQ. This standardized
measure was designed to quantify the impact of disease of
chronic airflow limitation on health and well-being.18
SGRQ scores have been shown to have good repeatability
and correlate with a range of established measures of disease
activity, such as spirometry, 6-minute walking distance, mor-
tality, and the incidence of COPD exacerbations.18,19 The to-
tal mean SGRQ score of patients who underwent mediastinal
repositioning and who completed the questionnaire was 25.9
6 4.9 (Table E2). In a recent study evaluating the association
between health-related QOL and disease severity using the
Global Initiative for Chronic Obstructive Lung Disease
guidelines, a total SGRQ score of 25 corresponded to aGlobal
Initiative for Chronic Obstructive Lung Disease stage I,
which was characteristic of patients with mild COPD.20 An
SGRQ total score of 25.9 also compares favorably to patients
in the National Emphysema Treatment Trial. The baseline
SGRQ total score was 52.56 12.6 for patients in the surgical
arm of the National Emphysema Treatment Trial and 53.66
12.7 for patients randomized to medical therapy.21 The
results of the QOL assessment suggest that the clinical symp-
tomatic improvement in patients with postpneumonectomy
syndrome who undergo mediastinal repositioning is more
significant than can be quantified by pulmonary function
studies alone. Mediastinal repositioning provides significant
improvement in relief of symptoms and enables patients to
return to a high level of activity and good functional status.
Moreover, these improvements in overall and disease-
specific health-related QOL appear to be durable.
Conclusions
Although we still have no explanation from this study or
other reports why extreme mediastinal displacement and
rotation occur in a small subset of patients who undergo
pneumonectomy, once postpneumonectomy syndrome is
identified and becomes symptomatic, patients should un-
dergo prompt surgical correction. Mediastinal repositioning
and placement of saline-filled breast implants can be
performed with low morbidity and mortality, and provide
significant and durable symptomatic relief to patients with
postpneumonectomy syndrome.
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TSDiscussion
Dr S. Murthy (Cleveland, Ohio). Dr Shen and colleagues have
provided a retrospective descriptive review of their experience of
the surgical management of a rare but devastating complication after
pneumonectomy. Although this a series of only 18 patients, it does
represent the largest report of its kind. It is unfortunate that the fol-
low-up of such a select group of patients is so incomplete, with only
13 of 17 patients who survived answering QOL questionnaires and
11 of 17 patients with full spirometric evaluation. Limited follow-up
in the context of such a small study can drastically bias the interpre-
tation of the results. To highlight this confound, the median length of
stay for the 11 patients with spirometry was almost double that of the
entire cohort at 11 days, and their mean length of stay was almost 40
days. Consequently, it is difficult for me to critically and meaningful
evaluate the findings. However, there are other aspects of the articlene 2008
Shen et al General Thoracic Surgery
G
TSthat are provocative and worthy of discussion, and I will direct my
attention to these.
I am intrigued by the operation and am impressed that such an
undertaking can be completed. Would you comment on the follow-
ing technical issues. How do you size the implants, and how are car-
diac hemodynamics measured intraoperatively and postoperatively
to prevent cardiac tamponade, ventricular arrhythmia, or decreased
venous return?
Dr Shen. The issue of how to size the implant is one that we be-
lieve is based in some ways on trial and error at the time of the op-
eration. After the pneumonectomy space has been opened and all of
the scar and adhesions have been mobilized to allow repositioning
of the herniated lung back to the proper side and repositioning
mediastinal structures, heart, and pericardium back to a central
position, we typically have used a technique where a measured
amount of saline is poured into the chest to be able to estimate the
volume of this often complex space. On the basis of the measured
volume of saline that is then removed from the chest, we then select
a number of breast implant sizers, test-sizers, before committing to
an actual implant. I think it also speaks to your second question on
how to monitor these patients postoperatively. Once the approxi-
mate volume has been selected, a critical technical point is that ex-
tensive monitoring of hemodynamics in terms of pulse, blood
pressure, and central venous pressure with central line monitoring
is important to be on the lookout for tamponade physiology. In ad-
dition, we use flexible bronchoscopy extensively throughout the
procedure once the mediastinal structures have been centrally lo-
cated, as well as after test placement of the implants and after the
chest has been closed. A final check once the patient has been turned
supine is also done. It’s worth noting that 4 of the 18 patients, after
partial closure of the chest, developed tamponade physiology and
had to have their partially closed incision reopened and the volume
adjusted. We also make use of intraoperative radiography with
a chest x-ray done at the end of the procedure, also looking for atel-
ectasis and overcorrection. So I think the issue of how to correctly
size the repositioning is intimately tied to the monitoring that’s
done in the procedure.
Dr Murthy. I have 2 other technical questions. Can you do this
extrapleurally? It seems like that might be an easier approach, not
having done one of these, but just thinking about it. Might tissue
expanders be a more appropriate choice to fill the space? This is
reported in the pediatric literature.
Dr Shen. The tasks that need to be achieved to successfully
reposition the mediastinum are that the scar and adhesions holding
the herniated lung, as well as the pericardium and other mediastinal
structures, need to be lysed and divided to allow one to centrally
reposition the mediastinum. Another important technical point to
emphasize is that the junction between the pneumonectomy stump
and the main bronchus needs to be extensively dissected and liber-
ated. That junction is oftentimes scarred to either the vertebral body
or the posterior mediastinum, and if you don’t achieve liberation and
complete lysis of that scar tissue there, you can still reposition the
mediastinal structures centrally, but if that tethering point hasn’t
been fully dissected, you’re still going to have mechanical compres-
sion of either the main or lobar bronchi and not achieve the desired
result. Whether or not that can be done easier from an extrapleural
approach, I don’t think so. To accomplish all those things, I think
it’s necessary to open the pneumonectomy space.The Journal of ThoraAs far as the issue of having adjustable tissue expanders, it has
been described extensively in the pediatric literature. I think that
for pediatric patients, to allow for further somatic growth, it is worth-
while to consider. In adult patients, it’s really not necessary. Several
other groups have reported the use of adjustable breast implants in
adults and have not found the need to make adjustments after
surgery.
Dr Murthy. I’ll skip to the last point. Finally, what might be the
mechanism for the apparent amelioration of this syndrome? Your
spirometry data actually argue against that you have solved
a functional airway obstruction. Other reports and my own common
sense would suggest that there would be an improvement in
spirometry measurements, especially FEV1, if a suspected airway
stenosis were to be relieved by your maneuvers. Perhaps it is the
relief of some intracardiac shunt or right atrial compression that
might lead to your improvement, and there is a syndrome, platyp-
nea-orthodeoxia, that has been reported as a possible putative mech-
anism for this kind of problem.
Dr Shen. We believe that there are 2 important physiologic
derangements that contribute to the overall syndrome. The first is
obviously a mechanical compression of the main bronchus or lobar
bronchus from the mediastinal shift, and so you get a functional and
a dynamic compressive upper airway obstruction. The second com-
ponent to the syndrome is due to the shift and herniation and over-
expansion of the residual lung. In patients with symptoms of
dyspnea and shortness of breath from this syndrome, I think it’s
a combination of these mechanisms, and each patient probably
has a mix of the effects of the overexpansion and herniation of the
lung, as well as the mechanical compression of the airway itself.
We believe that the relief that patients get from surgical correction
with mediastinal repositioning really comes from addressing both
of those issues independently. They are independent and also con-
nected. We did find in the spirometry data that the FVC decreased
in every patient, reflecting correction of the hyperexpansion. The
results with FEV1 have not been consistent. In Dr Grillo’s original
report, 7 patients had preoperative and postoperative spirometry,
4 patients had improvement in the FEV1, and 3 patients had decline.
In this current series of patients, 9 decreased and 2 increased. I think
the relief of dyspnea that patients get is probably a combination of
the correction of the overexpansion of the herniated lung and relief
of the mechanical obstruction on the airway. Depending on which
component of that is more important for any given patient, that’s
probably ultimately what affects the end result of relief of
symptoms.
Dr Murthy. That such a study could be done clearly demon-
strates the expertise of you and your group.
Dr J. Deslauriers (Quebec City, Quebec, Canada). What do
you think is the true incidence of this complication after pneumonec-
tomy?
Dr Shen. I think it’s extremely low. The only reported incidence
I’ve seen is an estimate of 1 in 640 pneumonectomies in children,
and obviously that’s much lower in adults.
Dr Deslauriers. So it would be extremely rare.
Dr Shen. Extremely rare.
Dr Deslauriers. Perhaps 1 in 1,000 or something like that?
Dr Shen. At least, yes.
Dr Deslauriers. My second question has to do with the some-
times associated bronchomalacia. This problem was mentioned incic and Cardiovascular Surgery c Volume 135, Number 6 1217
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of bronchial cartilages that may occur over time. Do you still just put
the intrapleural prosthesis, or do you do something else with the
bronchus to stabilize it?
Dr Shen.You raise an important point in the management of this
syndrome. It is difficult to determine which of these patients will
continue to have malacic changes in the airway after repositioning.
We typically do have these patients undergo awake bronchoscopy
so they can do provocative maneuvers. Sometimes you’re turning
them on their side. We look specifically at the time of bronchoscopy
to see if we can see the cartilaginous rings and dynamic change.
Even with all of those maneuvers, we have not been able to deter-
mine with any high degree of accuracy preoperatively which pa-
tients will continue to have malacia after successful repositioning.
In the original series of articles there were a number of things that
tried to address the malacia, including tracheal resection of that seg-
ment with reconstruction. Our current recommendation would be
that patients who have persistent malacic segments after reposition-
ing undergo prompt tracheal stenting.
Dr Deslauriers. So you just do the described operation, hoping
that the bronchus will be stabilized once the mediastinum is reposi-
tioned.
Dr Shen. Yes.
Dr Deslauriers. Do you perform a bronchoscopy while you’re
doing these procedures to see if the trachea has been repositioned
in the midline?
Dr Shen. Yes, absolutely. It’s one point I tried to stress with
some of the questions that Dr Murthy asked. It is an important
part of the technical conduct of the operation to be conducting flex-
ible bronchoscopy at multiple time points during the operation: once
the mediastinal structures have been repositioned into the central lo-
cation to assess how you’ve relieved the compression on the airway,
when the implants are placed, when you begin closing the chest, and
then, finally, again looking with a bronchoscope when the patients
are turned onto their back. In several of the cases in this series we
found that the patients had been overcorrected and required reopen-
ing the incision and removing some of the volume from their
implants.
Dr Deslauriers. Do these prostheses have a subcutaneous port
where you can aspirate fluid out if required?
Dr Shen. Yes there are implants with subcutaneous ports avail-
able.
Dr Deslauriers. So you don’t really need to reopen the chest.
Dr Shen. In 4 cases the chest had already been mostly closed,
and according to the intraoperative chest x-ray or bronchoscopy,
we found that they had actually been overcorrected, or they were
fine when they were in the lateral decubitus position. Then when
they were put supine again, they were overcorrected, and you
needed to be able to at least access the implants to remove some
volume. It would not be practical to routinely use the implants
with subcutaneous ports, because multiple implants are being placed
into the pneumonectomy space.
Dr Deslauriers. There were 3 patients in your series in whom
the pneumonectomy had been done for chronic lung disease, pre-
sumably for tuberculosis, or destroyed lung. Because these patients
usually already have their mediastinum shifted beforehand, why do
you think they developed this syndrome?
Dr Shen.Why was the mediastinum not fixed in those patients?1218 The Journal of Thoracic and Cardiovascular Surgery c JuDr Deslauriers. Well, usually it’s fixed, yes.
Dr Shen. The 3 patients who underwent operation for infectious
reasons had airway obstruction or were developing chronic pulmo-
nary infections. They were not necessarily patients who originally
underwent pneumonectomy for infectious causes, and because
they developed post-pneumonectomy syndrome I don’t think their
mediastinum was fixed before pneumonectomy.
Dr O. Adebo (Ibadan, Nigeria). I’m curious about the explana-
tion that you gave for the pathology. Most of the pneumonectomies
we do are for tuberculous destroyed lung, and at the end of the
pneumonectomy, the patient’s x-ray looks similar to that of patients
with postpneumonectomy syndrome, and they have no symptoms.
At the end of the pneumonectomy, the shift is as much, if not
more, than what you showed from your x-rays, and I’m curious
why those patients don’t seem to develop any respiratory problem
or symptoms despite the remarkable shift of the heart to the oper-
ated side, the pneumonectomized side, and we don’t make any ef-
fort, of course, to reposition it because the lungs are invariably
there already and the patient is well adjusted to it. So I’m wondering
why the explanation you gave would be the one to undermine this
syndrome.
Dr Shen. That’s an interesting observation. I don’t really have
a good explanation for why you don’t observe this syndrome in
those patients who essentially have a destroyed lung. Have you
ever seen this syndrome in patients who have undergone pneumo-
nectomy?
One of the continuing unanswered questions with this syndrome
is what are the predisposing factors, why is this such a rare syn-
drome, and are there factors that you could use to predict who is
more likely to develop this syndrome. We don’t really have any fur-
ther insight into that. It seems to be that this is more prevalent in
women and is more prevalent or more likely in patients who have
undergone right pneumonectomy. If we were to look at the total,
the 29 patients who were treated at Massachusetts General from
1979 to 2004, 22 of the 29 were women and 20 of the 29 patients
had a right pneumonectomy. But as to the real question, why do
some people get it and what are the predisposing factors, I think
we still don’t know.
DrW. Klepetko (Vienna, Austria). I would like to come back to
the importance of the hemodynamic component in the syndrome
that was stressed before. We recently identified a series of 5 or 6 pa-
tients in our patient cohort who developed severe postpneumonec-
tomy syndrome based on hemodynamic grounds either on the
reopening of the foramen ovale or on the compression of the right
atrium because of an unusually high elevation of the right dia-
phragm. These were all cases of right pneumonectomy. The leading
symptom in those patients was always severe hypoxemia, which
sometimes developed rapidly, and after the correction, either the clo-
sure of the intracardiac shunt or the repositioning of the diaphragm,
the hypoxemia was overcome and blood gases were pretty much
normalized.
What have you done to rule out such a hemodynamic compo-
nent? Could you give us some data on your blood gases, which
you did not show us. Were they impaired before the operation,
and how did they behave after the operation?
DrShen. I don’t have any data concerning preoperative and post-
operative blood gases to be able to share with you. In many of the
cases in this series that were evaluated, part of the preoperativene 2008
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tomy syndrome included echocardiography, and sometimes patients
also have transesophageal echo studies in the operating room.We are
looking specifically for alternative explanations for their symptoms.
Dr Klepetko. Have you seen in your large experience any pa-
tients with such a syndrome based on hemodynamic grounds only?
Dr Shen. No. There have been a couple of patients who contin-
ued to have similar symptoms after postpneumonectomy surgical re-
pair with repositioning and were found to have some cardiac issues
that were uncovered.
Dr T. Daniel (Charlottesville, Va). Congratulations, Dr Shen, on
an interesting presentation of this rare condition. I don’t know
whether operating on 3 additional patients makes me an expert,
but perhaps so. To suggest an answer to our colleague from Nigeria
as to causation, we looked at some of our patients and the patients in
Dr Grillo’s first report, and there seems to be a narrow interval be-The Journal of Thortween the sternum and the anterior portion of the vertebral body
that may show up in that difference in the sex incidence. Most
womenmight have less of a barrel chest, and thismay be a predispos-
ing factor. Certainly for all the pneumonectomies done in the world,
why such a small handful get it, we don’t know, but that may be
a predisposing cause.
To Dr Deslauriers’ question as to why we don’t use the adjust-
able port to modify these patients, 1 of 3 patients had a problem
in the postoperative unit that required returning to the operating
room and taking some fluid out. We used a breast prosthesis with
an implantable port subcutaneously on the first patient and thought
we got a good result, but 6 months after operation, she apparently
had a stress fracture of the polyethylene catheter connecting the
prosthesis to the extrathoracic position and had a, quote, ‘‘flat
tire’’ and redeveloped the syndrome, and we reoperated on her
with a successful result. So that’s a factor you wouldn’t think of.acic and Cardiovascular Surgery c Volume 135, Number 6 1219
